Video Latest - ecancer

How the WIN consortium achieves its goals

Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA

25 Apr 2019

The translational element of the WIN consortium

Dr Brian Leyland-Jones - WIN Head of Fundraising Committee

25 Apr 2019

Making oncology global with the WIN consortium

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain

25 Apr 2019

An overview of the WIN consortium

Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA

25 Apr 2019

The WIN symposium 2019

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA

25 Apr 2019

KEYNOTE-028 and KEYNOTE-158: Pembrolizumab as treatment for advanced SCLC after two or more lines of prior therapy

Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea

15 Apr 2019

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA

11 Apr 2019

Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma

Prof Sandip Patel - UC San Diego, San Diego, USA

11 Apr 2019

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

Prof Shoba Navai - Baylor College of Medicine, Houston, USA

11 Apr 2019

Gilteritinib improved survival for patients with acute myeloid leukaemia

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA

11 Apr 2019

Latest updates in melanoma research

Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands

21 Mar 2019

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice

Prof Josep Llovet, Dr Richard Finn

25 Feb 2019

Video